Abstract

Recently, there has been growing attention and effort to search for new microbicidal drugs which present different mode of action from those already existing, as an alternative to the global threat of fungal and bacterial multi drug resistance (MDR). Here we propose biological synthesis of SnO₂ nanoparticles using mammalian cells as an economic and ecofriendly platform. This presents a novel biogenic method for SnO₂ synthesis using metal binding peptides extracted from MCF-7 human cancer cells, which induces the biomineralization of SnO₂ nanoparticles. A series of electron donor functional groups and metal binding sites in these peptides reacts with Sn2+ ions and directs the growth of SnO₂ nanoparticles without addition of toxic redox and capping agents in the reaction system. Since peptides present reactive sites in aqueous solution at room temperature, a facile reaction environment can be easily achieved. Furthermore, by tuning the reactants' concentration and pH, the size, shape and 3D-structures of SnO₂ nanoparticles can be controlled. Peptides also ensure biocompatibility, and SnO₂ nanoparticles provide antibacterial properties, which broadens their applications in biomedical fields.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.